Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule
(2001) In Blood 98(11). p.602-602
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1118596
- author
- Lindén, Ola LU ; Tennvall, F ; Cavallin-Ståhl, Eva LU ; Darte, Lennart LU ; Ohlsson, Tomas G LU ; Hindorf, Cecilia LU ; Wingårdh, Karin LU and Strand, Sven-Erik LU
- organization
- publishing date
- 2001
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Blood
- volume
- 98
- issue
- 11
- pages
- 602 - 602
- publisher
- American Society of Hematology
- external identifiers
-
- wos:000172134102531
- ISSN
- 1528-0020
- language
- English
- LU publication?
- yes
- id
- 91742a47-6b56-462e-95a8-a56443459269 (old id 1118596)
- date added to LUP
- 2016-04-01 11:49:32
- date last changed
- 2018-11-21 20:00:41
@article{91742a47-6b56-462e-95a8-a56443459269, author = {{Lindén, Ola and Tennvall, F and Cavallin-Ståhl, Eva and Darte, Lennart and Ohlsson, Tomas G and Hindorf, Cecilia and Wingårdh, Karin and Strand, Sven-Erik}}, issn = {{1528-0020}}, language = {{eng}}, number = {{11}}, pages = {{602--602}}, publisher = {{American Society of Hematology}}, series = {{Blood}}, title = {{Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule}}, volume = {{98}}, year = {{2001}}, }